Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AROA BIOSURGERY LIMITED Director's Dealing 2021

Aug 18, 2021

64426_rns_2021-08-18_c393e3b4-b908-434b-92ef-2bcc463e9ca4.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Aroa Biosurgery Limited ARBN 638 867 473

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director James McLean
Date of last notice 27 July 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.


disclosed in this part.
Direct or indirect interest Direct
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the
relevant interest.
N/A
Date of change 19 August 2021
No. of securities held prior to change Direct
2,572,308 Fully Paid Ordinary Share
307,200
Options exercisable at $0.75
expiring 23 July 2025
Class Ordinary Fully Paid Shares
Number acquired 102,400
Number disposed -
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
AU$76,800.00
No. of securities held after change Direct
2,674,708 Fully Paid Ordinary Share
204,800
Options exercisable at $0.75
expiring 23 July 2025
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Exercise of Options

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract -
Nature of interest -
Name of registered holder
(if issued securities)
-
Date of change -
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in
relation to which the interest has changed
-
Interest acquired -
Interest disposed -
Value/Consideration
Note: If consideration is non-cash, provide details
and an estimated valuation
-
Interest after change -

Part 3 –[+] Closed period

Were the interests in the securities or contracts
detailed above traded during a+closed period where
prior written clearance was required?
No
If so, was prior written clearance provided to allow the
trade to proceed during this period?
N/A
If prior written clearance was provided, on what date
was this provided?
N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011